HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%
Market cap
$101.4B
P/E
15.3×
Fwd P/E
12.3×
Dividend yield
0.67%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100

HCA Healthcare, Inc. (HCA) EBITDA

Alert me on EBITDA

HCA Healthcare, Inc.'s EBITDA for fiscal 2025 was $15.6B, up 12.2% from $13.9B in fiscal 2024. Over the twelve months to 30 June 2026 it was $15.9B. Over the past ten years it has ranged from $8.0B (fiscal 2015) to $15.6B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. HCA Healthcare, Inc. ranks 1st of 52 Medical Care Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $15.6B 12.16%
FY2024 $13.9B 9.06%
FY2023 $12.8B 5.50%
FY2022 $12.1B (4.54%)
FY2021 $12.7B 25.87%
FY2020 $10.1B 1.82%
FY2019 $9.9B 10.10%
FY2018 $9.0B 8.66%
FY2017 $8.3B 0.15%
FY2016 $8.3B 3.80%

Quarterly newest first

Period EBITDA Change
Jun 2026 $4.0B 5.93%
Mar 2026 $3.8B (7.59%)
Dec 2025 $4.1B 6.42%
Sep 2025 $3.9B 0.36%
42 more quarters

Against its own ten years

Low $8.0B High $15.6B
Ten-year median $10.1B
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on HCA